Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 15;103(4):922-934.
doi: 10.1016/j.ijrobp.2018.11.016. Epub 2018 Nov 29.

Hepatocyte Transplantation: Quo Vadis?

Mark Barahman  1 , Patrik Asp  2 , Namita Roy-Chowdhury  3 , Milan Kinkhabwala  3 , Jayanta Roy-Chowdhury  4 , Rafi Kabarriti  5 , Chandan Guha  6
Affiliations
Review

Hepatocyte Transplantation: Quo Vadis?

Mark Barahman et al. Int J Radiat Oncol Biol Phys. .

Abstract

Orthotopic liver transplantation (OLT) has been effective in managing end-stage liver disease since the advent of cyclosporine immunosuppression therapy in 1980. The major limitations of OLT are organ supply, monetary cost, and the burden of lifelong immunosuppression. Hepatocyte transplantation, as a substitute for OLT, has been an exciting topic of investigation for several decades. HT is potentially minimally invasive and can serve as a vehicle for delivery of personalized medicine through autologous cell transplant after modification ex vivo. However, 3 major hurdles have prevented large-scale clinical application: (1) availability of transplantable cells; (2) safe and efficient ex vivo gene therapy methods; and (3) engraftment and repopulation efficiency. This review will discuss new sources for transplantable liver cells obtained by lineage reprogramming, clinically acceptable methods of genetic manipulation, and the development of hepatic irradiation-based preparative regimens for enhancing engraftment and repopulation of transplanted hepatocytes. We will also review the results of the first 3 patients with genetic liver disorders who underwent preparative hepatic irradiation before hepatocyte transplantation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Summary of mechanisms associated with preparative hepatic irradiation. (1) Increases LSEC apoptosis and sloughing, which increases porosity of sinusoids and increases migration of transplanted cells into liver parenchyma. (2) Enhancement of hepatocyte engraftment and integration in liver cords. (3) Reduction of Kupffer cell activity, which reduces phagocytic clearance of transplanted cells
In-text box 1:
In-text box 1:
Summary of mechanisms by which preparative hepatic irradiation improves cell engraftment and repopulation
Figure 2.
Figure 2.
The process of correction of a metabolic disease through ex-vivo gene therapy of autologous somatic cells such as fibroblasts. Fibroblasts are corrected ex-vivo and then reprogrammed and differentiated to hepatocyte-like-cells (HLCs). After transplantation, these hepatocytes integrate in the patient liver, where they produce deficient factors or enzymes.
See this image and copyright information in PMC

References

    1. Foundation A. American liver foundation - liver awareness month 2010 2010.
    1. AASLD. Global burden of liver disease substantial. In: The liver meeting 2013: American association for the study of liver diseases (aasld). Medscape Medical News 2013.
    1. Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clinics in liver disease 2008;12:733–746, vii. - PubMed
    1. Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest 2005;128:1179–1186. - PubMed
    1. OPTN. Organ procurement and transplantation network 2017.

Publication types